Last edition
News about "pulmonary arterial hypertension "
Corsair Pharma Collaborates with InstantGMP to Enhance Quality for Clinical Trials
Corsair Pharma is revolutionizing pulmonary arterial hypertension (PAH) treatment with its first product candidate: a prodrug of treprostinil delivered via a proprietary transdermal patch.
Pulmonary Arterial Hypertension | 30/01/2025 | By Aishwarya
Alembic Pharma Gets USFDA Tentative Approval for Selexipag for Injection
Alembic Pharmaceuticals has secured tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Selexipag for Injection, 1,800 mcg/vial.
Pulmonary Arterial Hypertension | 15/07/2024 | By Aishwarya | 188
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy